Ontology highlight
ABSTRACT: Objective
The aim of this study was to estimate the cost-savings attainable if all patients aged ≥65 years in Alberta, Canada, currently on intramuscular therapy were switched to oral therapy, from the perspective of a provincial ministry of health.Setting
Primary care setting in Alberta, Canada.Participants
Seniors of age 65 years and older currently receiving intramuscular vitamin B12 therapy.Intervention
Oral vitamin B12 therapy at 1000 μg/day versus intramuscular therapy at 1000 μg/month.Primary and secondary outcome measures
Cost saving from oral therapy over intramuscular therapy, from the perspective of the Alberta Ministry of Health, including drug costs, dispensing fees, injection administration fees, additional laboratory monitoring and phy
SUBMITTER: Houle SK
PROVIDER: S-EPMC4025453 | biostudies-literature | 2014 May
REPOSITORIES: biostudies-literature